
Research | VA Boise Health Care | Veterans Affairs
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:

ABOUT US Boise VA Medical Center hosts an active research program with 25 investigators conducting over 40 research projects and clinical trials. The research program has funding from NIH,
VA, foundations and industry, and has collaborative affiliations with University of Washington, Boise State University, and Idaho State University. CONTACT US Boise VA Medical Center
Research Office WHY VA RESEARCH MATTERS Research studies are important, because they can help provide: * An organized, methodical way to learn more about a specific concern * Answers about
whether or not a treatment is effective * A better understanding about which health care services are effective and efficient * Opportunities to test whether a drug or piece of equipment is
safe and effective * Answers to questions about the best way to treat or prevent an illness If you decide to volunteer for a research study, you can change your mind at any time. Your
decision to participate will not affect your VA benefits. CURRENT RESEARCH Current and ongoing clinical and basic science research includes projects in the following areas: * Infectious
Diseases * Antibiotic Stewardship * Microbiome * Oncology * Gene Therapy * Diabetic Wounds * PTSD * Depression * OCD * COPD PUBLIC INFORMATION INSTITUTIONAL BIOSAFETY COMMITTEE: The Boise VA
Medical Center’s Institutional Biosafety Committee (IBC) oversees research involving: (i) recombinant nucleic acid molecules, (ii) synthetic nucleic acid molecules, and (iii) cells,
organisms, and viruses containing such molecules. Comprised of subject matter experts and community members, the IBC conducts risk assessments to ensure a high standard of biosafety and
containment to protect research staff, the public, and the environment. The Boise VA IBC complies with NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
(April 2024), maintains registration with the NIH Office of Science Policy (OSP), and will publicly share meeting minutes.